Compare XNCR & VSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XNCR | VSEC |
|---|---|---|
| Founded | 1997 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 3.8B |
| IPO Year | 2013 | N/A |
| Metric | XNCR | VSEC |
|---|---|---|
| Price | $16.53 | $170.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | $22.44 | ★ $199.83 |
| AVG Volume (30 Days) | ★ 738.7K | 232.8K |
| Earning Date | 11-05-2025 | 10-27-2025 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | $150,132,000.00 | ★ $1,332,372,000.00 |
| Revenue This Year | $18.81 | $3.23 |
| Revenue Next Year | N/A | $14.80 |
| P/E Ratio | ★ N/A | $315.33 |
| Revenue Growth | 38.16 | ★ 67.77 |
| 52 Week Low | $6.92 | $88.69 |
| 52 Week High | $26.59 | $186.00 |
| Indicator | XNCR | VSEC |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 49.59 |
| Support Level | $16.58 | $162.11 |
| Resistance Level | $17.62 | $173.29 |
| Average True Range (ATR) | 0.96 | 6.39 |
| MACD | -0.14 | -0.28 |
| Stochastic Oscillator | 28.83 | 37.14 |
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management, and consulting services for land, sea, and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair, and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. The majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.